ApicHope
30072335.304.13% ( +1.40 )
ApicHope (300723)
ApicHope Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceuticals in China....
- Open
- 33.90
- High
- 35.66
- Low
- 33.70
- Prev. Close
- 33.90
- Volume
- 96.54K
- Turnover
- 339.07M
- Avg Price
- 35.12
- Bid/Ask Ratio
- --
- Amplitude
- 5.78%
- 52wk High
- 81.48
- Volume Ratio
- 0.54
- Turnover Ratio
- 2.14%
ApicHope Analyst Rating
View MoreForecast & Rating
Jul 7, 2026Price forecast
¥35.881.64%
Forecast & Rating-
0analysts
News
- 36Kr · Apr 1 at 02:03 AM
The three major A-share indices all closed higher
- Zhitong · Oct 29, 2025 at 09:42 AM
ApicHope released its performance for the first three quarters, with a net loss attributable to the parent company of 136 million yuan
- Zhitong · Oct 29, 2025 at 03:39 AM
ApicHope: The latest clinical results of the innovative drug deuterated benzbromarone for the treatment of gout stones were released at ACR 2025
- Zhitong · Oct 24, 2025 at 03:10 AM
ApicHope: Subsidiary's innovative drug APH03621 tablets approved for clinical trials
- Zhitong · Oct 17, 2025 at 02:58 AM
ApicHope's subsidiary obtains registration certificate for Methanesulfonic acid new strychnine injection
- Simplywall · Oct 6, 2025 at 01:50 AM
3 Asian Growth Stocks With Strong Insider Confidence
